| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.19 | 0.0006 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0007 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0007 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0009 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0009 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |